$0.01
-0.00(-13.33%)
Mkt Cap $162.0K
$0.01
$1.57
52-Week Range
At A Glance
1
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics.
2
No significant events in the past 90 days.
$162.0K
Market Cap
$534.6K
Revenue
-$5M
Net Income
Employees18
Fundamentals
How The Business Makes Money
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
Industry Drug Manufacturers - Specialty & Generic
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0001815903
ISINUS71678J3086
CUSIP71678J308
Phone973-242-0005
Address1185 Avenue of the Americas, New York City, NY, 10036, US
SEC EDGAR